Legal Representation
Attorney
Scott D. Woldow
USPTO Deadlines
Next Deadline
1341 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230905)
Due Date
September 05, 2029
Grace Period Ends
March 05, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
43 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 5, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 5, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 1, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jul 31, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jul 8, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jun 29, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jun 29, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jan 21, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 20, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jan 5, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jan 20, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jan 5, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 24, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 22, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 22, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jun 22, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 7, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 5, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 5, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 5, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 23, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 21, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 21, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 21, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 7, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 5, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 5, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 5, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 21, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 26, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 26, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 6, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 19, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 2, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 2, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 1, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 25, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 13, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 13, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 13, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 9, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 12, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 11, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Providing medical and scientific research information in the field of health and pharmaceuticals; Medical laboratory services, namely, scientific testing and screening services for testing of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma; Scientific research; product research and development services, including scientific, medical, pharmaceutical and blood products research and development services; pharmaceutical research and development; research and development of vaccines and medicines; Providing medical and scientific research information in the field of pharmaceuticals, clinical trials, blood conditions, blood illnesses and blood diseases, including via a global computer network; Providing medical and scientific research information in the field of clinical trials and pharmaceuticals
First Use Anywhere:
20200000
First Use in Commerce:
20200000
Class 044
Providing medical information and treatment information in the field of health; medical services; medical testing and screening services for diagnostic or treatment purposes; medical testing of human blood plasma for diagnostic or treatment purposes; collection of human blood plasma; medical services, namely, providing medical information concerning blood products, providing medical information concerning health products and services; health care, namely, providing health care information in person, via the internet, and through the distribution of printed matter
First Use Anywhere:
20200000
First Use in Commerce:
20200000
Additional Information
Design Mark
The mark consists of "Driven by" in black and in a stylized form followed by "Our Promise" in red in a stylized form.
Color Claim
The color(s) Black and Red is/are claimed as a feature of the mark.
Classification
International Classes
042
044